. 2020 Feb 26;12(3):610. doi: 10.3390/nu12030610

Table 4.

Changes in the serum biochemistry profiles, atherogenic index (AI), and cardiac risk index (CRI) determined from the sera of 5-uRCK-treated, ellagic acid-treated, or simvastatin-treated high-cholesterol diet (HCD)-fed rats. ** p < 0.01, *** p < 0.001 versus control (NCD) group, ^# p < 0.05, ^## p < 0.01, and ^### p < 0.001 versus the HCD group. All data are shown as the mean ± SD (n = 6–8).

Group.	Plasma Levels (mg/dl)								AI1	CRI
Group.	TC	HDL-C	LDL/VLDL	TG	ALT	AST	Apo B	Apo A1	AI1	CRI
NCD	82.68 ± 9.36	29.02 ± 0.90	13.57 ± 2.54	31.8 ± 5.10	23.00 ± 2.00	65.50 ± 7.51	1.89 ± 0.58	3.55 ± 0.35	1.80 ± 0.21	2.80 ± 0.21
HCD	158.8 ± 8.39 ***	16.57 ± 0.57 ***	78.00 ± 4.03 ***	107.5 ± 7.51 ***	40.50 ± 3.43 ***	110.50 ± 12.87 ***	6.33 ± 0.67 **	1.38 ± 0.20 **	8.90 ± 0.76 ***	9.90 ± 0.76 ***
5-uRCK 50	109.5 ± 5.56 ^###	24.39 ± 1.82 ^##	56.50 ± 1.73 ^###	48.60 ± 4.76 ^###	28.25 ± 1.32 ^#	63.20 ± 3.96 ^###	3.71 ± 0.72 ^#	2.99 ± 0.17 ^##	3.59 ± 0.36 ^###	4.58 ± 0.36 ^###
5-uRCK 100	112.6 ± 4.38 ^##	25.34 ± 2.26 ^##	60.75 ± 2.49 ^###	37.33 ± 4.67 ^###	27.67 ± 3.18 ^#	62.00 ± 5.03 ^###	3.25 ± 0.90 ^#	2.90 ± 0.23 ^##	3.40 ± 0.30 ^###	4.39 ± 0.30 ^###
5-uRCK 150	93.05 ± 7.41 ^###	26.78 ± 1.22 ^###	50.87 ± 1.73 ^###	55.33 ± 5.98 ^###	26.20 ± 2.71 ^##	50.50 ± 2.63 ^###	3.17 ± 0.77 ^##	3.0 ± 0.20 ^##	2.36 ± 0.24 ^###	3.36 ± 0.24 ^###
EA 2	144.5 ± 13.61	24.65 ± 2.48	68.91 ± 2.51	47.00 ± 4.21^###	27.33 ± 1.56##	61.83 ± 3.39 ^###	2.56 ± 0.59 ^#	2.38 ± 0.22 ^#	5.39 ± 0.54 ^###	6.39 ± 0.54 ^###
EA 4	98.19 ± 8.79 ^###	20.66 ± 2.23 ^#	66.96 ± 2.50 ^#	49.00 ± 5.49 ^###	21.20 ± 1.07 ^###	64.75 ± 7.19 ^###	2.44 ± 0.61 ^##	2.06 ± 0.18 ^#	3.66 ± 0.50 ^###	4.66 ± 0.50 ^###
SV	132.2 ± 6.16	25.85 ± 1.30 ^##	66.61 ± 1.36 ^#	53.67 ± 5.57 ^###	26.20 ± 2.92 ^##	55.75 ± 6.59 ^###	2.03 ± 0.66 ^##	2.25 ± 0.25 ^##	4.21 ± 0.23 ^###	5.21 ± 0.23 ^###